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Over centuries, the contributions of Europe to the science and prac-
tice of cardiology have been impressive and sustained. They began
with the seminal discovery of the circulation by William Harvey
and the publication of De motu cordis in 1616, and continued with
John Whithering in 1785 and Thomas Lauder Brunton 1863 who
were the first to attempt to treat cardiac diseases with herbs and
drugs. At the beginning of the 20th century,William Einthoven devel-
oped the electrocardiogram, and Werner Forssmann attempted the
first cardiac catheterization on himself. Both were awarded the
Nobel Prize for Medicine and Physiology, in 1924 and 1956, respect-
ively. The contributions of Sir Thomas Lewis to translating physiologi-
cal observations into the clinical arena also had a major impact.
Furthermore, seminal surgeons such as Clarence Crafoord at the
Karolinska Institutet, Russel Claude Baron Brock in London, and
Ake Senning in Zurich, among others, pioneered the surgical manage-
ment of patients with congenital heart disease. In the late 1960s, Hein
Wellens and his Dutch colleagues developed invasive electrophysio-
logy and changed the understanding of arrhythmias. In a bold step,
Andreas R. Gru¨ntzig opened the door to interventional cardiology
on 16 September 1977 when he first used a balloon catheter to
dilate a stenosis in the left anterior descending coronary artery in a
patient with angina pectoris at the University Hospital Zurich.
Outside academic institutions, the European pharmaceutical industry
also contributed importantly to improved patient care through the
development of novel drugs, includingb-blockers, diuretics, amiodar-
one, and calcium channel antagonists. Today European scientists and
clinicians lead the way in the clinical application of stem cells for the
treatment of cardiac disease.
From a single journal to an ESC
Journal Family
Initially, scientific findings were published in books, later in national
journals—up until recently a European journal in this discipline did
not exist. Only with the foundation of the European Society of
Cardiology (ESC) in 1949 did such a project become possible.
However, it took another 25 years until the first issue of the European
Heart Journalwas published under the editorship of Desmond G. Julian
in February 1980 (Figure 1). At that time, the European Heart Journal
appeared monthly. In 1989, Desmond Julian was succeeded by Henri
E. Kulbertus.
In 1995 Kim Fox took over the editorship of the official journal of
the ESC (Figure 1). Under his leadership, the European Heart Journal’s
impact factor rose from 1.425 in 1993 to 6.131 in 2003 when Frans
Van deWerf and his team of three Deputy Editors (Stefan Janssens,
Frank Rademakers, and Johan Vanhaecke) and 18 Associate Editors
from the University of Leuven took the helm. Today the European
Heart Journal appears bi-monthly and is one of the leading journals
in cardiovascular medicine. Of note, within 10 years, i.e. from
1996 until 2007, the impact factor of the European Heart Journal
grew impressively and steadily, and is currently close to 8. The
journal publishes original research, editorials, review articles,
cardiovascular flashlights, and correspondence. At present, 22 500
hard copies are printed every 2 weeks and distributed to cardiolo-
gists, scientists, and other physicians in Europe and other parts of
the world. In addition, the journal is regularly read by many online
subscribers at universities, hospitals, and other institutions.
It is the mission of the EuropeanHeart Journal to foster the develop-
ment of cardiology, further scientific exchanges, encourage personal
contacts, and establish standards of training for cardiologists and
those who work in the field of cardiovascular disease. The number
of manuscripts submitted has risen steadily over the years. Currently
the European Heart Journal receives more than 3500 manuscripts per
year and eventually accepts 15–19% of them for publication after
either minor or major revision. To ensure the highest scientific stan-
dards, all papers considered for publication are reviewed not only by
at least two experienced reviewers, but also by an experienced stat-
istician. Two-thirds of the submitted papers still come from European
countries (67%), but a substantial part also comes from Asia (14%)
and North America (12%). Importantly, the European Heart Journal
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publishes all the Guidelines of the ESC which are widely read and
extensively cited.
Besides its main journal, the ESC began to publish a growing
number of subspecialty journals (Figure 2). In 1999, the European
Journal of Heart Failure under the editorship of John Cleland was
started and received a growing number of manuscripts. Under
the leadership of Karl Swedberg since 2004, the now official
journal of the Heart Failure Association of the ESC expanded its
standing and its impact factor to 2.986. Published since 1967, the
ESC took over the scientific journal Cardiovascular Research that
focuses on basic mechanisms of cardiovascular disease. Other
associations including those devoted to echocardiography or pre-
vention and rehabilitation, respectively, later also established their
own journals (European Journal of Echocardiography and the
European Journal on Cardiovascular Prevention and Rehabilitation).
The latter journal, formerly under the editorship of David Wood
and Hugo Saner, recently reached an impact factor of 2.221; its
joint editors are now Pantaleo Gianuzzi and Diederick
E. Grobee. The European Heart Rhythm Association publishes
EUROPACE under the editorship of John Camm, a journal that is
devoted to electrophysiology and pacing. Finally, the European
Council on Cardiovascular Nursing and Allied Professions also
established their own journal, with Tiny Jaarsama as the editor of
the European Journal of Cardiovascular Nursing. Thus, today the
ESC Journal Family encompasses seven scientific journals covering
the whole spectrum of cardiovascular medicine and its subspecial-
ties. Furthermore, additonal publications are linked to the ESC
through its associations and working groups. Importantly, the
European Association on Percutaneous Coronary Interventions
(EAPCI) edits, under the leadership of Patrick Serruys,
Figure 1 Past Editors-in-Chief of European Heart Journal. (A) Desmond G. Julian (1980–1988), (B) Henri E. Kulbertus (1989–1994), (C) Kim
Fox (1995–2002), and (D) Frans Van de Werf (2003–2008).
Figure 2 Evolution of the impact factors of the journals of the ESC family over time.
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EuroIntervention, a journal concentrating on interventional cardiol-
ogy. Although not an official journal of the ESC and produced by
a different publisher, a close collaboration will be assured here
too thanks to Patrick W. Serruys’ engagement as a Deputy
Editor of the European Heart Journal.
Building on strength
The European Heart Journal became the flagship of the ESC, a
society that has grown impressively over the last two decades, as
has their annual congress that each year welcomes more than
26 000 delegates from more than 30 countries. The overwhelming
success of the annual congress has contributed importantly to the
growth of the European Heart Journal as its subscription is linked to
the numbers registered at the meeting. The increasing quality of
the annual ESC Congress and of its journal have both played a
major role in restoring the status of European cardiology interna-
tionally to the position that it held prior to the Second World
War.
The impressive turn around time to first decision of only 20 days
achieved by the last editorial team in Leuven under the leadership of
Frans Van de Werf as well as the availability of a fast track section
contributed to the growing attractiveness of the European Heart
Journal for manuscript submission. The journal’s turn around time
compares well with that of other leading cardiovascular journals
such as Circulation, with times of up to 28 days. Thus, today,
almost 30 years after the first issue appeared, the European Heart
Journal has an impressive record and hence also a bright future.
However, there are weaknesses as well that cannot be ignored.
Indeed, like many other journals linked to a major professional
society such as Circulation (American Heart Association) and the
Journal of the American College of Cardiology, its impact factor still
depends heavily on guidelines published by these bodies. It will
be a challenge, but also the ambition of the new editorial team
to make the Euroepan Heart Journal more attractive in an attempt
to obtain more original research papers as well as reviews of the
highest scientific quality from both sides of the Atlantic and Asia.
Indeed, our goals are simple and while the quality of competitive
journals in the USA is well recognized, we believe that the
European Heart Journal has the potential to attract the best
publications from both sides of the Atlantic. To that end, the
new editorial team went far beyond Zurich and invited Josep
Brugada, an eminent expert in the field of arrythmias and one of
the discoverers of the Brugada syndrome, as well as Patrick
W. Serruys, one of the world leading experts in interventional car-
diology, to become Deputy Editors (Figure 3). Furthermore, many
leading cardiologists from most European countries such as Paolo
Camici, Francesco Cosentino, Filippo Crea, Stephanie Dimmeler,
Keith Fox, Petros Nyannopolous, Thomas Mu¨nzel, Steffano
Taddei, Jens-Uwe Voigt, William Wijns, and others still to be
named will serve as Associate Editors.
Expanding globally
However, the new European Heart Journal looks far beyond Europe
and aims to become even more global than it already is. Indeed, the
new editorial team particularly welcomes contributions from US
and Canadian authors and hopes to increase North American sub-
missions. Indeed, for the first time in its history, the European Heart
Journalhas appointed aUSDeputyEditor.Wearehappy that Bernhard
Gersh fromtheMayoClinic, an experienced clinical cardiologistwith a
broad research scope, has accepted this important task (3). Further-
more, several US Associate Editors and numerous US members of
the Editorial Board are also part of the new editorial team.
We recognize the growing presence of basic and clinical inves-
tigators from the Asian-Pacific regions and indeed have asked
Hiroaki Shimokawa from Sendai University in Japan, a prominent
cardiovascular scientist and clinician, to become the associate
editor for Asia. These critically important links to the growing
scientific community in Japan, Korea, China, Australiasia (with the
special help of Henry Krum from Monash University in Melbourne
as Associate Editor), India, and other Asian countries are further
strengthened by a number of new members of the Editorial
Board from this part of the world.
We will foster cardiology worldwide not only by publishing orig-
inal research, editorials, reviews, and cardiovascular flashlights, but
also by a new feature of the European Heart Journal, i.e. ‘Cardio-
Pulse’. This novel feature will be incorporated into each issue at
the front and will report on issues of general interest such as
personalities, political aspects affecting our profession, historical
Figure 3 The new editors of the European Heart Journal (2009–2011): (A) Thomas F. Lu¨scher (Editor-in-Chief), (B) Jopip Brugada (Deputy
Editor, arrhythmias), (C) Ulf Landmesser (Deputy Editor, prevention and basic science), (D) Frank T. Ruschitzka (Deputy Editor, hypertension
and heart failure), (E) Patrick W. Serruys (Deputy Editor, interventional cardiology), and (F) Bernhard Gersh (US Deputy Editor).
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vignettes, cardiology practice, national healthcare systems, and
funding sources in different countries, as well as other subjects.
‘CardioPulse’ will be global and not restricted to Europe; indeed,
we intend to cover particularly topics relevant to India, China,
and Eastern Europe, as well as the Middle East and other
growing scientific communities. We are proud to announce that
with Andros Tofield we were able to attract an experienced
physician with a record in medical writing who is highly motivated
to provide, with the help of a large team of medical writers, inter-
esting features for the readers of the European Heart Journal.
Threats in a global world
The growing cardiovascular community and the corresponding
increase in clinical and translational research provides opportunities,
but also challenges. Indeed, the expansion of the leading cardiovas-
cular journals with a growing network of a number of subspecialty
products may attract even more papers to these publications. The
competitive advantage of such journal networks is their close inter-
action via electronic internet platforms, allowing for editorial
decisions beyond the main journal. Indeed, papers worthy of publi-
cation that just do not fit the criteria required to be accepted in the
main journal may still be of interest for a subspecialty journal. Within
such a network, an editorial decision ‘acceptable upon revision to
the subspecialty journal on . . . .’ may be of interest to submitting
authors as it allows for rapid publication with no change in format
and based on the existing reviews of the main journal. Nonetheless,
we face the threat of information overload and indeed from multiple
sources—our challenge will be to position the European Heart
Journal at the forefront of what is clinically and scientifically relevant
to the practice of cardiovascular medicine.
The ESC Journal Family is well positioned to respond to a chan-
ging world. In fact, many subspecialty journals already exist within
the ESC Journal Family (see above; Figure 4) and—in contrast to
those published by the American Heart Association and the Amer-
ican College of Cardiology—most of them already have formidable
impact factors. It is with great pleasure, therefore, that we are able
to announce that all editors of the ESC Journal Family will join the
new Editorial Board of the European Heart Journal as Associate
Editors. As of January 2009, therefore, the Editors of the European
Heart Journal will be closely linked with Karl Swedberg, Editor of
European Journal of Heart Failure, Michael Piper, Editor of Cardiovas-
cular Research, Jos Roelandt, Editor of the European Journal of Echo-
cardiography, John Camm, Editor of EUROPACE, Pantaleo Gianuzzi
and Diederick E. Grobee, new Editors of the Journal on Cardiovas-
cular Prevention and Rehabilitation, and Tiny Jaarsma, Editor of the
European Journal of Cardiovascular Nursing. Manuscripts that will
appear more suitable for a ESC subspecialty journal will be
Figure 4 The ESC Journal Family. All subspecialty journals are official ESC journals except EuroIntervention which is endorsed by the ESC only
and is the official journal of the EAPCI.
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handled directly by the ESC subspecialty journal editors at the time
of decision. If they agree with a decision ‘acceptable for the subspe-
cialty journal . . . with revision’ the authors will be informed
accordingly and will be able to submit the revised manuscript
directly to the ESC subspecialty journal based on the reviews of
the European Heart Journal, with possible acceptance.
The future is bright . . .
In spite of all the challenges that the new editorial team will face,
the future is bright: indeed, the cardiovascular community con-
tinues to grow; innovation has been an impressive feature of car-
diovascular medicine over the last decades and is likely to remain
so. The same applies to the dissemination of knowledge, and the
European Heart Journal is well positioned to expand its recog-
nition and readership within Europe and beyond. In this
respect, there are a number of new developments that will
enrich the journal, such as ‘CardioPulse’, but also invited reviews
authored by key opinion leaders and illustrated by a professional
designer (Table 1). Furthermore, we will welcome basic science
articles and reviews relevant to clinical practice. To that end,
we invited clinicians engaged in basic research as well as basic
scientists interested in clinical medicine to join our team. Ulf
Landmesser, an interventional cardiologist with a strong record
in stem cell research and prevention, will cover this area as a
Deputy Editor. Further, we are proud to announce that
Stephanie Dimmeler, a world expert on stem cell biology, will
act as an Associate Editor of the European Heart Journal. She
will be assisted by Associate Editors interested in basic research
from the Zurich team such as Christian Matter and Felix
C. Tanner. We aim to attract more basic science relevant to
clinical cardiology by the creation of a ‘fast track basic science’
section and by welcoming studies and reviews on basic
mechanisms of cardiovascular disease. ‘Yes, we can!’—with the
help of a great team as well as the readers and authors around
the world.
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Table 1 New features of the European Heart Journal 2009–2011
Feature Content
US Deputy Editor Bernard J. Gersh
Associate Editor Asia Hiroaki Shimokawa
Editors, basic science Ulf Landmesser (Deputy Editor), Stephanie Dimeler, Christian Matter, Felix C. Tanner (Associate Editors)
ESC subspecialty journal editors All Editors of ESC Journal Family will act as Associate Editors
ESC Journal Family Network of existing ESC journals with editorial exchange of manuscripts and joint decisions (see Figure 4)
CardioPulse Reports on personalities, history, healthcare systems, politics, and funding sources, among others
Illustrated editorials Editorials with designer-drawn figures
Invited reviews State-of-the-art articles by key opinion leaders around the world
Clinical ‘Fast Track’ Highly interesting and important clinical science with a time to first decision of 5 days
Basic ‘Fast Track’ Highly interesting and important basic science with clinical relevance with a time to first decision of 5 days
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